ArticleJCO precision oncology2021

Tumor Response Dynamics During First-Line Pembrolizumab Therapy in Patients With Advanced Non-Small-Cell Lung Cancer.

Mizuki Nishino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.